Xu et al., 2021 - Google Patents
Quantum dots in cell imaging and their safety issuesXu et al., 2021
- Document ID
- 16017940661788643617
- Author
- Xu Q
- Gao J
- Wang S
- Wang Y
- Liu D
- Wang J
- Publication year
- Publication venue
- Journal of Materials Chemistry B
External Links
Snippet
When quantum dots are used as fluorescent probes or drug tracers for in vivo imaging, the quantum dots in the blood will come into direct contact with vascular endothelial cells. Thus, it is necessary to study whether quantum dots can affect endothelial function after being …
- 239000002096 quantum dot 0 title abstract description 125
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Xu et al. | Quantum dots in cell imaging and their safety issues | |
| Lu et al. | Graphene quantum dots for optical bioimaging | |
| Molaei | Carbon quantum dots and their biomedical and therapeutic applications: a review | |
| Li et al. | Theranostic carbon dots with innovative NIR-II emission for in vivo renal-excreted optical imaging and photothermal therapy | |
| Tabish et al. | Biocompatibility and toxicity of graphene quantum dots for potential application in photodynamic therapy | |
| Dai et al. | Two-dimensional tantalum carbide (MXenes) composite nanosheets for multiple imaging-guided photothermal tumor ablation | |
| Zhang et al. | Shining luminescent graphene quantum dots: Synthesis, physicochemical properties, and biomedical applications | |
| Meng et al. | Fabricating Aptamer‐Conjugated PEGylated‐MoS2/Cu1. 8S Theranostic Nanoplatform for Multiplexed Imaging Diagnosis and Chemo‐Photothermal Therapy of Cancer | |
| Chen et al. | Current advances in lanthanide‐doped upconversion nanostructures for detection and bioapplication | |
| Gu et al. | Recent advances in design and fabrication of upconversion nanoparticles and their safe theranostic applications | |
| Wang et al. | Upconversion nanoparticles in biological labeling, imaging, and therapy | |
| Zeng et al. | pH-responsive Fe (III)-gallic acid nanoparticles for in vivo photoacoustic imaging-guided photothermal therapy | |
| Hu et al. | Indocyanine green-loaded polydopamine-reduced graphene oxide nanocomposites with amplifying photoacoustic and photothermal effects for cancer theranostics | |
| Nurunnabi et al. | Photoluminescent graphene nanoparticles for cancer phototherapy and imaging | |
| Mettenbrink et al. | Bioimaging with upconversion nanoparticles | |
| Wu et al. | Engineered g-C3N4 quantum dots for tunable two-photon imaging and photodynamic therapy | |
| Zhao et al. | In situ aqueous synthesis of genetically engineered polypeptide-capped Ag 2 S quantum dots for second near-infrared fluorescence/photoacoustic imaging and photothermal therapy | |
| Behboudi et al. | Carbon quantum dots in nanobiotechnology | |
| Sengupta et al. | A review on synthesis, toxicity profile and biomedical applications of graphene quantum dots (GQDs) | |
| Jiang et al. | 808 nm light triggered lanthanide nanoprobes with enhanced down-shifting emission beyond 1500 nm for imaging-guided resection surgery of tumor and vascular visualization | |
| Xiao et al. | Polypyrrole-encapsulated iron tungstate nanocomposites: a versatile platform for multimodal tumor imaging and photothermal therapy | |
| Li et al. | A self-assembled nanoplatform based on Ag2S quantum dots and tellurium nanorods for combined chemo-photothermal therapy guided by H2O2-activated near-infrared-II fluorescence imaging | |
| Tu et al. | Recent developments in carbon dots: a biomedical application perspective | |
| Lin et al. | Emerging Low‐Dimensional Nanoagents for Bio‐Microimaging | |
| Hu et al. | Rational Molecular Engineering of Organic Semiconducting Nanoplatforms for Advancing NIR‐II Fluorescence Theranostics |